Landor has partnered with Invengene for a full-scale brand transformation, covering brand positioning, voice, and visual identity to bring Invengene’s ambition to life in the competitive global injectables market.
For the work, Landor focused on precision, innovation, and strategic action to craft a distinct and recognizable identity that reflects the brand’s role in accelerating growth while the logo reflects their dedication to precision and innovation.
A key highlight of the collaboration is the introduction of CalMarks, a signature element that embodies precision and reliability in every Invengene product. The three Ns in ‘Invengene’ symbolize the brand’s commitment to innovation, quality, and customer satisfaction.
” The injectables industry is complex, which often hampers both effective healthcare and category advancement. There was an opportunity for Invengene to step in to solve this jigsaw,” Invengene’s Founders said.
“Fuelled by Landor’s strategic vision and creative expertise, our new vision-driven identity showcases precision and reliability in every solution making us poised to lead the way in revolutionizing the injectables market. Our partnership with Landor exemplifies a synergistic collaboration driving innovation in the pharmaceutical landscape.”
Ronita Mukerjee, Executive Director – Client Services, Landor India added, “Through a purpose-driven brand positioning and a unique brand identity; we were able to help Invengene stand out and stand for something in a very cluttered category. We are proud to have played a role in elevating Invengene as a dynamic growth catalyst in the injectables space.”
The collaboration between Landor and Invengene signals a new chapter for the pharmaceutical industry, where innovation meets purpose to drive meaningful change and growth, the agency said.